Latest Period
Q2 2026
Security Snapshot
Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (BBNX) Institutional Ownership
CUSIP: 08659B102
13F Institutional Holders and Ownership History from Q1 2025 to Q2 2026
Institutions Reporting
132
Shares (Excl. Options)
47,972,706
Price
$15.67
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share (the "Shares")
- Symbol
- BBNX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 47,972,706
- Total 13F value
- $752,412,561
- Portfolio coverage rank
- 0%
- Share change
- -1,387,676
- Value change
- -$13,893,761
- Number of holders
- 132
- Shares outstanding
- 45,769,231
- SEC-reported price per share
- $15.17
- Insider filing price
- $15.17
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BBNX - Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (the "Shares") is tracked under CUSIP 08659B102.
- 132 institutions reported positions in Q2 2026.
- 13 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 128 to 132 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $493,788,078 to $752,412,561.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 132 institutions filings for Q2 2026.
Security key
08659B102
Latest holder period
Q2 2026
13F holders
132
13D/G owners
13
CIK / CUSIP context first
Open Q2 2026 holders
BBNX full holder history
Beta Bionics, Inc. SEC filings
Beta Bionics, Inc. company facts
Beta Bionics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 08659B102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
13
Security
BBNX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 13% | +19% | $52,677,024 | +$9,643,640 | 5,945,488 | +22% | Eventide Asset Management, LLC | 31 Mar 2026 |
| Soleus Capital Group, LLC | 9.8% | $38,580,879 | 4,354,501 | Levy Guy | 31 Mar 2026 | |||
| Zone Healthcare Holdings, LLC | 9.9% | +25% | $85,717,590 | +$17,618,729 | 4,313,920 | +26% | Dapice Joshua J. | 30 Sep 2025 |
| MORGAN STANLEY | 8.6% | +26% | $74,305,196 | +$16,109,185 | 3,739,567 | +28% | Morgan Stanley | 30 Sep 2025 |
| Farallon Capital Partners, L.P. | 8.1% | -18% | $31,966,171 | -$6,839,920 | 3,607,920 | -18% | Dapice Joshua J. | 31 Mar 2026 |
| Sands Capital Life Sciences Pulse Fund II, L.P. | 8.2% | +13% | $48,410,732 | +$5,636,946 | 3,570,113 | +13% | Sands Capital Life Sciences Pulse Fund II. L.P. | 30 Jun 2025 |
| Divisadero Street Capital Management, LP | 6.9% | $48,154,597 | 3,072,985 | Divisadero Street Capital Management, LP | 17 Jul 2026 | |||
| BlackRock, Inc. | 6.4% | $55,215,708 | 2,778,764 | BlackRock, Inc. | 30 Sep 2025 | |||
| Point72 Asset Management, L.P. | 5.2% | $34,190,043 | 2,290,023 | Point72 Asset Management, L.P. | 18 Feb 2026 | |||
| RTW INVESTMENTS, LP | 4.5% | -20% | $17,720,000 | -$4,430,000 | 2,000,000 | -20% | RTW Investments, LP | 31 Mar 2026 |
| PERCEPTIVE ADVISORS LLC | 3.7% | $21,609,324 | 1,593,608 | Perceptive Advisors LLC | 31 Mar 2025 | |||
| MILLENNIUM MANAGEMENT LLC | 1.8% | -70% | $15,835,993 | -$29,602,207 | 796,964 | -65% | Millennium Management LLC | 30 Sep 2025 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.3% | $9,948,400 | 595,000 | Farallon Capital Management, L.L.C. | 30 Jun 2026 |
As of 30 Jun 2026, 132 institutional investors reported holding 47,972,706 shares of Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (BBNX). This represents 105% of the company’s total 45,769,231 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
94%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| EVENTIDE ASSET MANAGEMENT, LLC | 14% | 6,253,673 | +5.2% | 1.3% | $98,053,951 |
| Soleus Capital Management, L.P. | 9.6% | 4,393,714 | +0.9% | 2.4% | $68,849,498 |
| MORGAN STANLEY | 9.3% | 4,266,822 | +0.93% | 0% | $66,861,101 |
| Sands Capital Alternatives, LLC | 8.1% | 3,708,043 | 0% | 9.5% | $58,105,034 |
| BlackRock, Inc. | 7.3% | 3,340,171 | +9.9% | 0% | $52,340,479 |
| Point72 Asset Management, L.P. | 4.9% | 2,254,683 | -11% | 0.05% | $35,330,883 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 1,782,346 | +3.1% | 0% | $27,929,362 |
| Vestal Point Capital, LP | 3.5% | 1,600,000 | -28% | 0.59% | $25,072,000 |
| RTW INVESTMENTS, LP | 3.3% | 1,500,000 | -25% | 0.2% | $23,505,000 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.9% | 1,324,000 | 0% | 0.22% | $20,747,080 |
| Omega Fund Management, LLC | 2.9% | 1,316,183 | 0% | 11% | $20,624,588 |
| Eversept Partners, LP | 2.7% | 1,249,441 | -12% | 1.1% | $19,578,740 |
| Divisadero Street Capital Management, LP | 2.4% | 1,113,802 | 0.41% | $17,453,277 | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,073,452 | +15% | 0% | $16,824,964 |
| STATE STREET CORP | 2.1% | 970,192 | +2.5% | 0% | $15,202,909 |
| MILLENNIUM MANAGEMENT LLC | 2.1% | 956,244 | +11% | 0.01% | $14,984,343 |
| Balyasny Asset Management L.P. | 1.9% | 855,682 | +38% | 0.02% | $13,408,537 |
| PERCEPTIVE ADVISORS LLC | 1.8% | 832,944 | -1.2% | 0.2% | $13,052,232 |
| JPMORGAN CHASE & CO | 1.5% | 703,356 | +129% | 0% | $11,957,052 |
| Bruce & Co., Inc. | 1.5% | 665,700 | +21% | 2.8% | $10,431,519 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.3% | 595,000 | -84% | 0.05% | $9,323,650 |
| BANK OF AMERICA CORP /DE/ | 1.2% | 546,650 | +301% | 0% | $8,566,005 |
| GOLDMAN SACHS GROUP INC | 1.2% | 537,105 | +343% | 0% | $8,416,435 |
| Trexquant Investment LP | 1.1% | 494,435 | +105% | 0.05% | $7,747,796 |
| Tri Locum Partners LP | 1.1% | 493,344 | 0.95% | $7,730,700 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
6
Latest
Q2 2026
Rows shown
1-6 of 6
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 47,972,706 | $752,412,561 | -$13,893,761 | $15.67 | 132 |
| 2026 Q1 | 49,288,407 | $493,788,078 | -$73,044,020 | $10.02 | 128 |
| 2025 Q4 | 47,221,349 | $1,439,223,888 | +$22,363,225 | $30.47 | 159 |
| 2025 Q3 | 48,310,134 | $959,915,542 | +$85,339,869 | $19.87 | 127 |
| 2025 Q2 | 44,848,348 | $652,883,600 | +$53,846,940 | $14.56 | 114 |
| 2025 Q1 | 41,702,710 | $507,967,865 | +$504,374,335 | $12.24 | 102 |